123 related articles for article (PubMed ID: 36925282)
1. Accurate and rapid quantification of PD-L1 positive exosomes by a triple-helix molecular probe.
Fan Z; Weng Q; Li Y; Zeng T; Wang J; Zhang H; Yu H; Dong Y; Zhao X; Li J
Anal Chim Acta; 2023 Apr; 1251():340984. PubMed ID: 36925282
[TBL] [Abstract][Full Text] [Related]
2. Clinical significance of PD-L1 expression in serum-derived exosomes in NSCLC patients.
Li C; Li C; Zhi C; Liang W; Wang X; Chen X; Lv T; Shen Q; Song Y; Lin D; Liu H
J Transl Med; 2019 Oct; 17(1):355. PubMed ID: 31665020
[TBL] [Abstract][Full Text] [Related]
3. Blood exosome PD-L1 is associated with PD-L1 expression measured by immunohistochemistry, and lymph node metastasis in lung cancer.
Zhang Z; Jin W; Xu K; Zheng X; Zhou Y; Luo M; Yan C; Zheng X; Jin E
Tissue Cell; 2022 Dec; 79():101941. PubMed ID: 36228365
[TBL] [Abstract][Full Text] [Related]
4. Triple-color fluorescence co-localization of PD-L1-overexpressing cancer exosomes.
Wei J; Zhu K; Chen Z; Yang Z; Yang K; Wang Z; Zong S; Cui Y
Mikrochim Acta; 2022 Apr; 189(5):182. PubMed ID: 35394232
[TBL] [Abstract][Full Text] [Related]
5. Identification of programmed death ligand-1 positive exosomes in breast cancer based on DNA amplification-responsive metal-organic frameworks.
Cao Y; Wang Y; Yu X; Jiang X; Li G; Zhao J
Biosens Bioelectron; 2020 Oct; 166():112452. PubMed ID: 32738648
[TBL] [Abstract][Full Text] [Related]
6. Tracing Tumor-Derived Exosomal PD-L1 by Dual-Aptamer Activated Proximity-Induced Droplet Digital PCR.
Lin B; Tian T; Lu Y; Liu D; Huang M; Zhu L; Zhu Z; Song Y; Yang C
Angew Chem Int Ed Engl; 2021 Mar; 60(14):7582-7586. PubMed ID: 33382182
[TBL] [Abstract][Full Text] [Related]
7. Transforming growth factor beta orchestrates PD-L1 enrichment in tumor-derived exosomes and mediates CD8 T-cell dysfunction regulating early phosphorylation of TCR signalome in breast cancer.
Chatterjee S; Chatterjee A; Jana S; Dey S; Roy H; Das MK; Alam J; Adhikary A; Chowdhury A; Biswas A; Manna D; Bhattacharyya A
Carcinogenesis; 2021 Feb; 42(1):38-47. PubMed ID: 32832992
[TBL] [Abstract][Full Text] [Related]
8. Integrated microfluidic system for isolating exosome and analyzing protein marker PD-L1.
Lu Y; Ye L; Jian X; Yang D; Zhang H; Tong Z; Wu Z; Shi N; Han Y; Mao H
Biosens Bioelectron; 2022 May; 204():113879. PubMed ID: 35180692
[TBL] [Abstract][Full Text] [Related]
9. Exosomes from Melatonin Treated Hepatocellularcarcinoma Cells Alter the Immunosupression Status through STAT3 Pathway in Macrophages.
Cheng L; Liu J; Liu Q; Liu Y; Fan L; Wang F; Yu H; Li Y; Bu L; Li X; Wei W; Wang H; Sun G
Int J Biol Sci; 2017; 13(6):723-734. PubMed ID: 28655998
[TBL] [Abstract][Full Text] [Related]
10. Deconstruction of Heterogeneity of Size-Dependent Exosome Subpopulations from Human Urine by Profiling N-Glycoproteomics and Phosphoproteomics Simultaneously.
Zheng H; Guan S; Wang X; Zhao J; Gao M; Zhang X
Anal Chem; 2020 Jul; 92(13):9239-9246. PubMed ID: 32495629
[TBL] [Abstract][Full Text] [Related]
11. Personalized detection of circling exosomal PD-L1 based on Fe
Pang Y; Shi J; Yang X; Wang C; Sun Z; Xiao R
Biosens Bioelectron; 2020 Jan; 148():111800. PubMed ID: 31678824
[TBL] [Abstract][Full Text] [Related]
12. Exosomal PD-L1 promotes tumor growth through immune escape in non-small cell lung cancer.
Kim DH; Kim H; Choi YJ; Kim SY; Lee JE; Sung KJ; Sung YH; Pack CG; Jung MK; Han B; Kim K; Kim WS; Nam SJ; Choi CM; Yun M; Lee JC; Rho JK
Exp Mol Med; 2019 Aug; 51(8):1-13. PubMed ID: 31399559
[TBL] [Abstract][Full Text] [Related]
13. PD-L1 in circulating exosomes of Merkel cell carcinoma.
Zanella A; Vautrot V; Aubin F; Avoscan L; Samimi M; Garrido C; Gobbo J; Nardin C
Exp Dermatol; 2022 Jun; 31(6):869-877. PubMed ID: 34994009
[TBL] [Abstract][Full Text] [Related]
14. Microfluidic-based exosome isolation and highly sensitive aptamer exosome membrane protein detection for lung cancer diagnosis.
Zhao L; Wang H; Fu J; Wu X; Liang XY; Liu XY; Wu X; Cao LL; Xu ZY; Dong M
Biosens Bioelectron; 2022 Oct; 214():114487. PubMed ID: 35780540
[TBL] [Abstract][Full Text] [Related]
15. Microporous PdCuB nanotag-based electrochemical aptasensor with Au@CuCl
Chang L; Wu H; Chen R; Sun X; Yang Y; Huang C; Ding S; Liu C; Cheng W
J Nanobiotechnology; 2023 Mar; 21(1):86. PubMed ID: 36906540
[TBL] [Abstract][Full Text] [Related]
16. Expression profiles and clinical value of plasma exosomal Tim-3 and Galectin-9 in non-small cell lung cancer.
Gao J; Qiu X; Li X; Fan H; Zhang F; Lv T; Song Y
Biochem Biophys Res Commun; 2018 Apr; 498(3):409-415. PubMed ID: 29452091
[TBL] [Abstract][Full Text] [Related]
17. Homogeneous, Low-volume, Efficient, and Sensitive Quantitation of Circulating Exosomal PD-L1 for Cancer Diagnosis and Immunotherapy Response Prediction.
Huang M; Yang J; Wang T; Song J; Xia J; Wu L; Wang W; Wu Q; Zhu Z; Song Y; Yang C
Angew Chem Int Ed Engl; 2020 Mar; 59(12):4800-4805. PubMed ID: 31912940
[TBL] [Abstract][Full Text] [Related]
18. Clinical Significance of PD-L1
Theodoraki MN; Yerneni SS; Hoffmann TK; Gooding WE; Whiteside TL
Clin Cancer Res; 2018 Feb; 24(4):896-905. PubMed ID: 29233903
[TBL] [Abstract][Full Text] [Related]
19. Endoplasmic Reticulum Stress Causes Liver Cancer Cells to Release Exosomal miR-23a-3p and Up-regulate Programmed Death Ligand 1 Expression in Macrophages.
Liu J; Fan L; Yu H; Zhang J; He Y; Feng D; Wang F; Li X; Liu Q; Li Y; Guo Z; Gao B; Wei W; Wang H; Sun G
Hepatology; 2019 Jul; 70(1):241-258. PubMed ID: 30854665
[TBL] [Abstract][Full Text] [Related]
20. Reactive oxygen species reprogram macrophages to suppress antitumor immune response through the exosomal miR-155-5p/PD-L1 pathway.
Li X; Wang S; Mu W; Barry J; Han A; Carpenter RL; Jiang BH; Peiper SC; Mahoney MG; Aplin AE; Ren H; He J
J Exp Clin Cancer Res; 2022 Jan; 41(1):41. PubMed ID: 35086548
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
